The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma Dirk VordermarkUlrike Höller Short Communication Open access 28 March 2023 Pages: 433 - 435
A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers Adela AdemajParaskevi D. VeltsistaOliver Riesterer Original Article Open access 29 August 2022 Pages: 436 - 444
4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy Pixiao ZhouRuihao WangShuxu Zhang Original Article 04 November 2022 Pages: 445 - 455
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study Cem OnalEzgi OymakGokhan Ozyigit Original Article 30 November 2022 Pages: 456 - 464
Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography Takaya InagakiHiroshi DoiYasumasa Nishimura Original Article 07 December 2022 Pages: 465 - 476
CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study Andrei FodorMartina MoriNadia Di Muzio Original Article 29 December 2022 Pages: 477 - 484
Improving CBCT image quality to the CT level using RegGAN in esophageal cancer adaptive radiotherapy Hao WangXiao LiuYongkang Zhou Original Article Open access 23 January 2023 Pages: 485 - 497
Image-based features in machine learning to identify delivery errors and predict error magnitude for patient-specific IMRT quality assurance Ying HuangYifei PiZhiyong Xu Original Article Open access 29 March 2023 Pages: 498 - 510
Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy—description of two cases Felix MehrhofPaula BergengruenFelix Schönrath Case Study Open access 03 February 2023 Pages: 511 - 519
Bestrahlen oder nicht bestrahlen bei älteren Patientinnen mit Low-Risk-Mammakarzinom? Erkenntnisse aus den 10-Jahres-Daten der PRIME-II-Studie Elena Sperk Literatur kommentiert Open access 27 March 2023 Pages: 520 - 521
Keine abskopalen Effekte bei Kombination von Immuntherapie und stereotaktischer Radiotherapie bei Merkel-Zell-Karzinomen Sören SchnellhardtUdo S. GaiplMarkus Hecht Literatur kommentiert Open access 12 April 2023 Pages: 522 - 524